Orbimed Capital is a fund manager in New York with $8.00 bn assets under management.
Company profile
Employees
Incorporated
Location
Fiscal year end
SEC CIK
IRS number
134133323
SEC advisor number
801-61952
Address
Orbimed Capital
601 LEXINGTON AVENUE
54TH FLOOR
NEW YORK
NY 10022
601 LEXINGTON AVENUE
54TH FLOOR
NEW YORK
NY 10022
Phone
(212) 739-6400
Ownership
Fund structure | AUM | Fund type |
---|---|---|
Orbimed Capital LLC | $8.00 bn | |
Orbimed Partners Master Fund Limited | $3.39 bn | Hedge Fund |
Orbimed Partners, LTD. | ||
Orbimed Partners, L.P. |
Latest filings (excl ownership)
No filings
Latest ownership filings
4
Kinnate Biopharma Inc.
5 Apr 24
13F-NT
Notice of holdings reported by another manager
14 Feb 24
144
Keros Therapeutics, Inc.
11 Dec 23
13F-NT
Notice of holdings reported by another manager
14 Nov 23
144
Galecto, Inc.
2 Oct 23
4
ARS Pharmaceuticals, Inc.
31 Aug 23
144
Galecto, Inc.
30 Aug 23
144
Galecto, Inc.
21 Aug 23
144
Galecto, Inc.
15 Aug 23
13F-NT
Notice of holdings reported by another manager
14 Aug 23